STATE STREET CORP - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 50 filers reported holding ATYR PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$263,557
-26.9%
166,8080.0%0.00%
Q2 2023$360,305
+106.9%
166,808
+101.2%
0.00%
Q1 2023$174,107
-52.1%
82,908
-50.0%
0.00%
Q4 2022$363,138
+45.8%
165,816
+100.0%
0.00%
Q3 2022$249,000
+6.0%
82,9080.0%0.00%
Q2 2022$235,000
-47.1%
82,9080.0%0.00%
Q1 2022$444,000
+6.2%
82,908
+48.1%
0.00%
Q4 2021$418,000
-17.7%
55,9990.0%0.00%
Q3 2021$508,000
+88.8%
55,999
+1.4%
0.00%
Q2 2021$269,00055,1990.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tikvah Management LLC 1,225,833$9,157,0002.55%
Stonepine Capital Management, LLC 525,531$3,926,0001.80%
Telemetry Investments, L.L.C. 176,782$1,321,0001.70%
TANG CAPITAL MANAGEMENT LLC 1,113,453$8,317,0001.67%
VR Adviser, LLC 1,565,000$11,691,0001.60%
Deep Track Capital, LP 1,100,000$8,217,0000.58%
EAM Investors, LLC 252,280$1,885,0000.31%
EAM Global Investors LLC 152,792$1,141,0000.20%
FEDERATED HERMES, INC. 5,222,250$39,010,0000.07%
Alyeska Investment Group, L.P. 674,975$5,042,0000.06%
View complete list of ATYR PHARMA INC shareholders